Wes Streeting, the Health Secretary and a cancer survivor himself, has set out a new National Cancer Plan aimed at significantly boosting cancer survival rates in England. The plan aims for 75% of patients to be cured or living well five years after being diagnosed with cancer, with the goal of saving an additional 320,000 lives by 2035.

Streeting, who underwent advanced robotic surgery for kidney cancer, plans to expand the use of this technology within the NHS. Additionally, efforts will be made to detect cancers early by expanding community diagnostic centers operating 12 hours a day, seven days a week.

Despite advancements in cancer treatment worldwide, England lags behind many European countries in survival rates, with some cancer types showing lower survival rates compared to countries like Croatia, Poland, and Romania. Streeting emphasized the importance of improving cancer care standards in the UK, drawing from his own experience and expressing gratitude for the care he received.

The government’s plan includes a significant increase in robot-assisted surgeries, aiming to conduct half a million such procedures by 2035. This initiative is expected to lead to smaller incisions, fewer complications, and ultimately free up hospital beds.

To support these efforts, the NHS will allocate £2.3 billion to conduct 9.5 million additional cancer tests by 2029. This funding will facilitate the acquisition of more scanners, automated testing, and the expansion of community diagnostic centers to ensure more timely and efficient cancer diagnoses.

Professor Peter Johnson from NHS England emphasized the importance of early diagnosis and timely treatment in improving cancer survival rates. The plan also includes a commitment to meet all cancer waiting time standards by 2029, aiming for 85% of patients to start treatment within 62 days of referral.

Sarah Scobie from the Nuffield Trust highlighted the challenges in meeting these targets, given the existing gaps in investment and staff in the UK healthcare system. Cancer Research UK’s chief executive, Michelle Mitchell, stressed the importance of addressing delays in treatment initiation for cancer patients.

The UK government’s ambitious plan aims to make significant strides in cancer care, focusing on early detection, timely treatment, and ultimately improving survival rates for cancer patients across the country.